Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Amyloid beta precursor protein binding protein 2 (APPBP2) is a highly conserved, multi-domain protein that acts as a substrate recognition receptor within the Cullin 2-RING ubiquitin ligase complex (CRL2). It specifically recognizes C-terminal R-x-x-G degron motifs in substrate proteins, leading to targeted ubiquitin-mediated degradation. APPBP2 interacts with microtubules, regulates the transport and processing of beta-amyloid precursor protein—a protein implicated in Alzheimer's disease—and is linked to cancer biology. Structural insight has established its role in protein turnover and provided a foundation for the design of small-molecule ligands such as PROTACs for selective degradation of pathological targets[2][4][5]. Overexpression of APPBP2 has clinical relevance as a biomarker in several cancer types.
Drugs or PROTACs targeting APPBP2 typically function by promoting ubiquitin-mediated degradation of proteins via recognition of C-degron motifs
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Amyloid beta precursor protein binding protein 2 (APPBP2).